Cyanobacteria bloom, Charles River
Just a few months after the reveal of Ori Biotech’s automated cell and gene therapy manufacturing platform IRO, the technical ...
In the wake of a second quarter that saw revenues decline by 3.2%, contract research organization Charles River ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $218.3, with a ...
Charles River Laboratories International is cutting over 600 jobs, citing softening demand from pharmaceutical clients.